Frequently Asked Questions

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:21

Li FAN

Written by
Dept. Radiology
Shanghai Changzheng Hospital, China
Associate chief physician, Master’s supervisor
Focus on Chest imaging, especially lung cancer screening and COPD
Academic position:
Secretary, ASTR
Vice president, Youth Committee of Chinese Society of Radiology
Vice president, Youth Committee of Shanghai Society of Radiology
Committee member, Respiratory Committee of Chinese Association of Radiologists
Sunday, 08 August 2021 11:21

Ricardo Santos

Written by
Dr. Sales dos Santos has a Medical degree from the Federal University of Bahia in Brazil, surgical residency at the State University of Campinas, Sao Paulo, Brazil, and also research and clinical fellowships in general thoracic surgery and lung transplantation at the Allegheny General Hospital and University of Pittsburgh Medical Center (Pennsylvania, USA) from 2002 to 2007. He was an Instructor in Minimally Invasive CT surgery at Boston Medical Center, and faculty at the Boston University School of Medicine (BUSM, Massachusetts, USA) from 2007 to 2009.
Since 2010 Dr. Sales dos Santos has worked as a thoracic surgeon at Hospital Israelita Albert Einstein. Among his attributions he collaborated with the development of the Minimally Invasive Thoracic Surgery Program, EBUS and the Lung Cancer Screening Study (BRELT1-Propulmão). Currently, He is also a board member of the “ProAr Foundation”, of the IASLC's Early Detection Committee and a Visiting Professor at SENAI Cimatec University Center in Bahia, Brazil, where he is developing the next phase of “Propulmão”: a pioneer initiative on Lung Cancer Screening and treatment in Brazil.
Sunday, 08 August 2021 11:21

Ugo Pastorino

Written by
Ugo Pastorino is Director of the Thoracic Surgery Division at the Istituto Nazionale Tumori of Milan (INTM) since 2003. Graduated in Medicine in 1979 at the University of Milan and specialised in Emergency Surgery, Oncology and Thoracic Surgery. In 1991 launched the International Registry of Lung Metastases. From 1982 to 1988 acted as Executive Director of the European School of Oncology (ESO). Appointed as consultant thoracic surgeon at the Royal Brompton Hospital of London in 1994, Head of Thoracic Surgery at the European Institute of Oncology (IEO) from 1998, and Scientific Director of INTM in 2014/2015. From 2001 to 2014 was Associate Editor of the Journal of the National Cancer Institute. Author of 393 papers, with an H-index of 62 (Scopus), is actually the PI of three prospective trials on lung cancer screening with LDCT and circulating biomarkers (MILD, BioMILD, SMILE). In 2016 he received the Joseph Cullen Award for Research on Lung Cancer Prevention from the IASLC.
Sunday, 08 August 2021 11:21

Ichiro Yoshino

Written by
Ichiro Yoshino, M.D., Ph.D. is chairman and professor of department of general thoracic surgery, Chiba University Graduate School of Medicine, and chief of general thoracic surgery, Chiba University Hospital, Japan. Prof. Yoshino currently serves as the president of Japanese Association for Chest Surgery, and the secretary general of Japanese Joint Committee of Lung Cancer Registry, that has been contributed to TNM revision of IASLC/AJCC. He is also involved in nation-wide clinical trials concerning lung cancer surgery and perioperative multimodal treatments. He has more than 300 scientific articles and one of opinion readers in Japan.
Sunday, 08 August 2021 11:21

Clayton D Pruett

Written by
Sunday, 08 August 2021 11:21

Renee Arndt

Written by
Sunday, 08 August 2021 11:21

Russell J Clark

Written by
Sunday, 08 August 2021 11:21

Yu Deng

Written by
Sunday, 08 August 2021 11:21

Fan Wu

Written by
Page 35 of 371